Sandnes D, Sand T E, Sager G, Brønstad G O, Refsnes M R, Gladhaug I P, Jacobsen S, Christoffersen T
Exp Cell Res. 1986 Jul;165(1):117-26. doi: 10.1016/0014-4827(86)90537-9.
Hepatocytes from regenerating rat liver show an enhanced epinephrine-sensitive adenylate cyclase activity and cAMP response, which may be involved in triggering of the cell proliferation. We have determined adrenergic receptors and adenylate cyclase activity in hepatocytes isolated at various time points after partial hepatectomy. The number of beta-adrenergic receptors, measured by binding of [125I]iodocyanopindolol ([125I]CYP) to a particulate fraction prepared from isolated hepatocytes, increased rapidly after partial hepatectomy as compared with sham-operated or untreated controls. The maximal increase, which was observed at 48 h, was between 5- and 6-fold (from approximately 1 800 to approximately 10 500 sites per cell). Thereafter, the number of beta-adrenergic receptors decreased gradually. Competition experiments indicated beta 2-type receptors. Parallelism was found between the change in the number of beta 2-adrenergic receptors and the isoproterenol-responsive adenylate cyclase activity. The number of alpha 1-adrenergic receptors, determined by binding of [3H]prazosin, was transiently lowered by about 35% at 18-24 h, with no significant change in Kd. Although the results of this study do not exclude the possibility of post-receptor events, they suggest that the increased number of beta 2-adrenergic receptors is a major factor responsible for the enhanced catecholamine-responsive adenylate cyclase activity in regenerating liver.
再生大鼠肝脏的肝细胞显示出增强的肾上腺素敏感性腺苷酸环化酶活性和cAMP反应,这可能参与触发细胞增殖。我们测定了部分肝切除术后不同时间点分离的肝细胞中的肾上腺素能受体和腺苷酸环化酶活性。通过[125I]碘氰吲哚洛尔([125I]CYP)与从分离的肝细胞制备的微粒体部分结合来测量β-肾上腺素能受体的数量,与假手术或未处理的对照相比,部分肝切除术后其数量迅速增加。在48小时观察到的最大增加为5至6倍(从每个细胞约1800个位点增加到约10500个位点)。此后,β-肾上腺素能受体的数量逐渐减少。竞争实验表明为β2型受体。发现β2-肾上腺素能受体数量的变化与异丙肾上腺素反应性腺苷酸环化酶活性之间存在平行关系。通过[3H]哌唑嗪结合测定的α1-肾上腺素能受体数量在18至24小时短暂降低约35%,Kd无显著变化。尽管本研究结果不排除受体后事件的可能性,但它们表明β2-肾上腺素能受体数量的增加是再生肝脏中儿茶酚胺反应性腺苷酸环化酶活性增强的主要因素。